Tekla Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$15.8M	Buy	173,248 +38,124	+28%	+$3.29M	0.62%	43
2023 Q1	$8.91M	Buy	135,124 +68,698	+103%	+$3.96M	0.34%	61
2022 Q4	$3.43M	Sell	66,426 -199,650	-75%	-$10.6M	0.13%	89
2022 Q3	$18.2M	Sell	266,076 -46,116	-15%	-$2.73M	0.74%	38
2022 Q2	$14.1M	Buy	312,192 +116,372	+59%	+$5.31M	0.55%	52
2022 Q1	$9.95M	Hold	195,820	–	–	0.35%	61
2021 Q4	$9.26M	Hold	195,820	–	–	0.3%	74
2021 Q3	$6.45M	Buy	195,820 +43,282	+28%	+$2.43M	0.21%	94
2021 Q2	$9.64M	Hold	152,538	–	–	0.31%	83
2021 Q1	$6.54M	Sell	152,538 -63,479	-29%	-$3M	0.23%	103
2020 Q4	$12.4M	Hold	216,017	–	–	0.43%	68
2020 Q3	$6.52M	Buy	216,017 +42,523	+25%	+$1.27M	0.24%	90
2020 Q2	$5.67M	Hold	173,494	–	–	0.22%	93
2020 Q1	$4.65M	Buy	173,494 +42,495	+32%	+$1.51M	0.21%	90
2019 Q4	$4.01M	Buy	130,999 +32,215	+33%	+$892K	0.15%	125
2019 Q3	$2.38M	Buy	+98,784	New	+$2.72M	0.1%	129